- Home
- DMB vs CBUS Comparison
DMB vs CBUS Comparison
Compare DMB & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DMB | CBUS |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.4M | 208.7M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | DMB | CBUS |
|---|---|---|
| Price | $10.50 | $1.88 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 52.3K | ★ 676.1K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 4.17% | N/A |
| EPS Growth | N/A | ★ 74.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,639,000.00 |
| Revenue This Year | N/A | $126.00 |
| Revenue Next Year | N/A | $110.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.58 | $1.09 |
| 52 Week High | $11.28 | $4.19 |
Technical Indicators
Market Signals| Indicator | DMB | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 39.97 | 35.60 |
| Support Level | $10.27 | $1.35 |
| Resistance Level | $10.73 | $2.48 |
| Average True Range (ATR) | 0.12 | 0.31 |
| MACD | 0.00 | -0.14 |
| Stochastic Oscillator | 39.95 | 11.09 |
Price Performance
Historical ComparisonAbout DMB BNY Mellon Municipal Bond Infrastructure Fund Inc.
BNY Mellon Municipal Bond Infrastructure Fund, Inc. is a diversified closed-end management investment company. The fund's investment objective is to provide as high a current income exempt from regular federal income tax as is consistent with the preservation of capital. It invests in transportation, energy and utilities, social infrastructure, and water and environmental sectors.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.